Search the Newsreel

Gabelli Funds LLC Reduces Stake in Amgen Inc. $AMGN

Gabelli Funds LLC decreased its stake in Amgen Inc. by 4.6% in the first quarter of 2026, selling 2,735 shares and holding 57,165 shares valued at approximately $20.1 million. Despite this reduction, Amgen reported strong Q1 earnings, surpassing analyst expectations with an EPS of …

Aristotle Atlantic Partners LLC Purchases Shares of 4,000 Amgen Inc. $AMGN

Aristotle Atlantic Partners LLC acquired a new position of 4,000 shares in Amgen Inc. (NASDAQ:AMGN) during the first quarter, valued at approximately $1.4 million. Other institutional investors like Brighton Jones LLC, Sivia Capital Partners LLC, Schnieders Capital Management LLC, Main Street Financial Solutions LLC, …

IAMGOLD Corporation Revenue Breakdown – TSX:IMG

Clarkston Capital Partners LLC Reduces Stock Holdings in Affiliated Managers Group, Inc. $AMG

Clarkston Capital Partners LLC has reduced its stake in Affiliated Managers Group (AMG) by 65.3% in the first quarter, though AMG remains its third-largest holding. Despite the reduction by Clarkston, other institutional investors increased their positions, and analysts generally maintain a "Moderate Buy" rating …

Amgen Inc. (AMGN) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive financial information for Amgen Inc. (AMGN), including its current stock price, recent trading activity, key events, and detailed financial metrics. It also offers an overview of the company's business, product portfolio, and analyst insights, along with tools for …

AMG to Announce Second Quarter and First Half Results on July 30, 2026

Affiliated Managers Group, Inc. Conference Call Scheduled for 8:30 a.m. Eastern Time JUPITER, Fla, July 24, 2026 (GLOBE NEWSWIRE) -- AMG (NYSE: AMG) will report financial and operating results for the second quarter and six months ended June 30, 2026 on Thursday, July 30, …

IAG|IAMGOLD Corp|Price:18.193|Chg%:+0.033

This article from TradingKey provides a comprehensive stock analysis of IAMGOLD Corp (IAG), highlighting its strong fundamentals, high growth potential, and relatively healthy financial state. Despite a recent weak stock market performance, the company shows steady revenue and profit growth. The analysis also covers …

Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains

Amgen Inc. (AMGN) shares rose 1.22% on Friday, closing at $376.04. Despite this daily gain, the stock underperformed compared to the broader market, as the S&P 500 Index increased by 0.05% and the Dow Jones Industrial Average rose by 0.46%. This marks the second …

Amgen hands in data package in hopes of FDA hearing for Tavneos defense

Amgen has submitted a data package to the FDA to defend the approval of its ANCA-associated vasculitis drug, Tavneos, which it acquired from ChemoCentryx. The drug faces regulatory scrutiny due to safety flags and concerns about its pivotal trial. Amgen is seeking a hearing …

AMG4997162 Bond Profile — Key Metrics

This article provides a bond profile for AMG4997162, issued by Affiliated Managers Group, Inc. Key details include a 3.3% coupon rate, maturity on June 15, 2030, and an outstanding amount of $350 million USD. The bond has a face value of $1,000 USD and …

Amgen Inc. Revenue Breakdown – HAN:AMG

Amgen Inc. generated €31.29 billion in revenue last year, with Human Therapeutics being its highest-performing segment at €29.93 billion. The United States was the largest regional contributor, accounting for €22.49 billion of the company's revenue. These figures show a slight decrease in overall revenue …

Amgen submits new data to challenge FDA's proposal to withdraw Tavneos

Amgen has submitted new data to the FDA to challenge the proposed withdrawal of its rare-disease drug Tavneos from the U.S. market. The company argues that over 70 real-world studies involving more than 2,200 patients support the drug's effectiveness and safety, despite the FDA's …

Amgen Inc. $AMGN Shares Sold by Oak Associates Ltd. OH

Oak Associates Ltd. OH reduced its stake in Amgen Inc. by 11.8% in the first quarter, selling 14,795 shares and retaining 110,466 shares valued at approximately $38.9 million. Despite this, Amgen exceeded Q1 earnings estimates with an EPS of $5.15 and revenue of $8.62 …

Compound Planning Inc. Buys 7,818 Shares of Amgen Inc. $AMGN

Compound Planning Inc. increased its stake in Amgen Inc. by 83.4% during Q1, now owning 17,195 shares valued at $6.05 million. Other institutional investors like Norges Bank, Capital World Investors, and State Street Corp also significantly increased their holdings in Amgen. The article also …

Amgen Statement on FDA Data Submission for TAVNEOS® (avacopan)

Amgen has submitted extensive data and analyses to the U.S. Food and Drug Administration (FDA) to support its request for a hearing regarding TAVNEOS (avacopan), aiming to preserve access to this treatment for severe active ANCA-associated vasculitis (AAV) in the U.S. The company strongly …

Bank of Nova Scotia Has $110.56 Million Stock Position in Amgen Inc. $AMGN

Bank of Nova Scotia reduced its stake in Amgen Inc. by 15.8% in Q1, selling 58,745 shares and retaining 314,227 shares valued at approximately $110.6 million. Amgen's recent earnings exceeded expectations, with EPS of $5.15 and revenue of $8.62 billion, a 5.8% increase year-over-year. …

What Amgen (AMGN)'s Blocked Colorado Enbrel Price Cap Means For Shareholders

A federal judge recently blocked Colorado's aggressive plan to cap the price of Amgen's arthritis drug Enbrel, easing a near-term pricing concern for the company. While this reduces uncertainty for Enbrel, it doesn't eliminate the broader risk of future drug pricing reforms and reimbursement …

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Amgen (AMGN) stock rose by 1.48% to $371.47, outperforming the down-trending S&P 500, Dow, and Nasdaq in a recent trading session. The biotech giant is expected to report Q3 2026 earnings per share of $5.6 (a 6.98% decrease year-over-year) and revenue of $9.45 billion …

Will Iamgold (IAG) Beat Estimates Again in Its Next Earnings Report?

Iamgold (IAG) is positioned for another earnings beat in its upcoming quarterly report, according to Zacks Equity Research. The company has a strong track record, surprising estimates by an average of 27.10% over the past two quarters, and currently holds a positive Zacks Earnings …

Affiliated Managers Group (AMG) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Affiliated Managers Group (AMG) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its …

Walleye Capital LLC Decreases Stock Holdings in Iamgold Corporation $IAG

Affiliated Managers Group (AMG) Expected to Announce Quarterly Earnings on Thursday

Amgen (AMGN) Settles Lawsuit for $74 Million Over Tax Disclosure Delay

Amgen has agreed to a $74 million settlement over allegations it delayed disclosing a potential $10.7 billion tax liability to the U.S. IRS, stemming from alleged improper profit allocation to a Puerto Rico subsidiary. Despite this setback, Amgen holds a strong GF Score™ of …

Is Affiliated Managers Group (AMG) Stock Undervalued Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …

Working capital per share of Amgen Inc. – BCS:AMGN1

This article provides the working capital per share for Amgen Inc., traded under the symbol AMGN1 on the Santiago Stock Exchange. It indicates that the market is currently closed with no trades recorded. The information is presented within the context of TradingView's financial data …

Danica Pension Livsforsikringsaktieselskab Invests $12.14 Million in Amgen Inc. $AMGN

Danica Pension Livsforsikringsaktieselskab has acquired a new stake in Amgen Inc. (NASDAQ:AMGN), purchasing 34,491 shares valued at approximately $12.14 million in the first quarter. This comes as Amgen reported strong Q1 earnings, surpassing analyst estimates, and received revised price targets from several Wall Street …

ABN Amro Investment Solutions Cuts Holdings in Amgen Inc. $AMGN

ABN Amro Investment Solutions reduced its stake in Amgen Inc. by 18.1% in the first quarter, selling 12,829 shares and holding 58,173 shares valued at $20.47 million. Several other institutional investors also adjusted their holdings, with some increasing stakes while ABN Amro decreased its …

Amgen (AMGN) Clears An Enbrel Overhang, Is The Stock Fully Priced?

A recent court decision blocking Colorado's planned 70% price cap on Enbrel has removed a regulatory overhang for Amgen (AMGN). While a community narrative suggests Amgen is slightly overvalued at $359.98, Simply Wall St's DCF model indicates the stock is materially undervalued with an …

Amgen (AMGN) Stock Looks Reasonable On Earnings While Cash Flow Stays Strong

Amgen's stock has shown a 75.2% return over five years, with its current valuation presenting a mixed picture. A Discounted Cash Flow (DCF) analysis suggests a significant undervaluation of 46.5%, estimating an intrinsic value of $685 per share, based on strong future cash flow …

MGRD Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for Affiliated Managers Group, Inc.'s (MGRD) 4.200% Junior Subordinated Notes due 2061. It details the current coupon rate of 4.20% and specifies that the next interest payment is scheduled for September 30, 2026. The information highlights essential coupon …

Amgen Settles Investor Suit Over Tax Liability for $74 Million

Amgen Inc. has agreed to a $74 million settlement in an investor lawsuit. The suit alleged that the pharmaceutical company delayed informing investors about potential tax liabilities totaling $10.7 billion with the IRS. The proposed settlement covers investors who purchased Amgen stock between July …

More Than Dry Eyes: The Many Faces of Sjögren’s Disease

This article highlights the diverse manifestations of Sjögren's disease through the experiences of three women—Elaine, Courtney, and Rose—demonstrating that the autoimmune condition extends far beyond typical dry eyes and mouth. It explores the varied paths to diagnosis, the evolving and often debilitating symptoms like …

Amgen agrees to $74M settlement to resolve investor lawsuit over potential $10.7B tax bill

Amgen has reached a $74 million settlement with investors who accused the company of concealing a potential $10.7 billion U.S. tax bill, which they claimed artificially inflated Amgen's share price. The settlement, filed in federal court, does not include an admission of liability from …

Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill

Amgen has agreed to a $74 million settlement in a shareholder lawsuit. The lawsuit alleged that the biotechnology company delayed disclosing a potential $10.7 billion tax liability to the IRS for underreporting taxes between 2010 and 2015, primarily due to improper profit shifting to …

Commerzbank Aktiengesellschaft FI Raises Position in Amgen Inc. $AMGN

Commerzbank Aktiengesellschaft FI significantly increased its stake in Amgen Inc. by 31.1% in the first quarter, now holding 194,785 shares valued at $68.535 million. This makes Amgen its 23rd largest holding. Other institutional investors also adjusted their positions in Amgen, while one insider, SVP …

Andra AP fonden Has $17.72 Million Stock Position in Amgen Inc. $AMGN

Andra AP fonden reduced its stake in Amgen Inc. by 18.9% in the first quarter, now holding 50,366 shares valued at $17.72 million. Other institutional investors also adjusted their positions, and 76.50% of Amgen's stock is institutionally owned. Amgen's stock opened at $364.17, and …